Climb Bio, Inc. CLYM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.72M+21.7% | -$17.52M-35.9% | -$12.89M-48.7% | -$8.67M+58.3% | -$20.78M-147% | ||
| $38K+26.7% | $30K+3.4% | $29K-23.7% | $38K— | $0— | ||
| $1.61M+53.9% | $1.04M-73.8% | $3.98M+292% | $1.01M-49.9% | $2.02M+22.0% | ||
| -$1.41M-179% | $1.79M+556% | -$393K-523% | $93K+29.2% | $72K— | ||
| -$1.53M-796% | $220K— | —— | —— | $2.04M+98.7% | ||
| $0— | $0-100% | $162K-87.9% | $1.34M+13,320% | $10K-95.3% | ||
| —— | $0— | $0— | —— | —— | ||
| -$62K-59.0% | -$39K+33.9% | -$59K-130% | $200K+439% | -$59K-63.9% | ||
| -$14.38M+8.0% | -$15.64M-28.8% | -$12.14M-8.9% | -$11.15M+27.8% | -$15.43M-180% | ||
| —— | —— | $109K— | —— | —— | ||
| —— | $0— | $0— | —— | —— | ||
| -$12.96M-151% | $25.54M— | —— | —— | -$42.75M+20.0% | ||
| $5K-92.3% | $65K— | $0— | $0— | $0-100% | ||
| $5K+124% | -$21K— | $0— | $0— | $0-100% | ||
| $0— | $0— | $0-100% | $24K+200% | -$24K— | ||
| -$27.33M— | —— | —— | -$6.34M+89.1% | -$58.21M+1.3% | ||
| $305K-40.3% | $511K-2.3% | $523K-8.4% | $571K-14.6% | $669K+27.4% | ||
| -$21K— | —— | —— | —— | -$24K— | ||
| -$1.53M-796% | $220K— | —— | —— | $2.04M+98.7% | ||
| -$62K-59.0% | -$39K+33.9% | -$59K-130% | $200K+439% | -$59K-63.9% | ||
| -$929K-232% | $706K-48.9% | $1.38M+123% | $621K+133% | -$1.89M-269% | ||
| —— | $21.5K0.0% | $21.5K0.0% | $21.5K0.0% | $21.5K— | ||
| —— | $0— | $0— | —— | —— | ||
| $0— | $0— | $0-100% | $24K+200% | -$24K— | ||
| -$62K-59.0% | -$39K+33.9% | -$59K-130% | $200K+439% | -$59K-63.9% | ||
| $58K+1.8% | $57K+1.8% | $56K+14.3% | $49K+25.6% | $39K+18.2% | ||
| —— | —— | —— | —— | —— | ||
| $73K— | —— | —— | —— | $69K+56.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Climb Bio, Inc. generate?
- Climb Bio, Inc. (CLYM) generated -$53.3M in operating cash flow over the trailing twelve months.
- What is Climb Bio, Inc.'s free cash flow?
- After $109.0K of capital expenditures, Climb Bio, Inc.'s free cash flow was -$41.0M over the trailing twelve months.
- Where does Climb Bio, Inc.'s cash flow data come from?
- Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.